Takeda Chemical Industries Ltd. said Wednesday its group net profit logged a year-on-year rise of 2.2 percent in the first half, hitting 133.67 billion yen.
This marks the fourth straight year in which the firm has posted record-high interim earnings.
The nation's largest drug maker attributed the improvement to brisk sales of mainstay prescription drugs both at home and overseas.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.